FY2024 EPS Estimates for Henry Schein Increased by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Zacks Research boosted their FY2024 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Tuesday, November 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $4.76 for the year, up from their prior estimate of $4.73. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.21 EPS, Q1 2025 earnings at $1.17 EPS, Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.31 EPS, Q4 2025 earnings at $1.40 EPS, FY2025 earnings at $5.15 EPS, Q1 2026 earnings at $1.35 EPS, Q2 2026 earnings at $1.39 EPS and FY2026 earnings at $5.61 EPS.

Several other research firms have also weighed in on HSIC. Robert W. Baird reduced their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Six analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Price Performance

HSIC opened at $77.05 on Thursday. Henry Schein has a 52-week low of $63.67 and a 52-week high of $82.63. The company has a 50 day moving average of $71.36 and a two-hundred day moving average of $69.89. The company has a market cap of $9.61 billion, a P/E ratio of 31.96, a P/E/G ratio of 2.23 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 EPS.

Hedge Funds Weigh In On Henry Schein

Several large investors have recently added to or reduced their stakes in the company. Cromwell Holdings LLC lifted its position in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new position in Henry Schein in the second quarter worth about $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein in the second quarter worth about $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the period. Finally, Farther Finance Advisors LLC grew its holdings in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insider Transactions at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.